ANALYST
Dr. Schlaepfer has more than 25 years of scientific leadership and research accomplishments,
including working in endocrinology for more than a decade and completing a Ph.D. in integrative
physiology and genetics of addiction from the University of Colorado, Boulder. During her tenure
at University of Colorado Medical School, she studied the role of lipids in insulin resistance and
hormone-related cancers. Specifically, the combination of hormonal and metabolic inhibitors to
reduce tumor growth and increase the sensitivity to standard of care treatments. Isabel brings to
CVrg strong scientific and analytical skills, as well as interdisciplinary experience in biomedical
research.